Skip to content

Trial Summary

A phase II clinical trial of nivolumab monotherapy in previously treated recurrent or metastatic microsatellite instability high (MSI-H) colorectal cancer.

Acronym:

CA209-8HW

ACTRN/NCT /ethics:

 

Scientific title:

 

Trial & Patient Characteristics

Cancer TypeBowel
Trial TypeTreatment
PhasePhase II
Age Range18+ years
SexBoth
Tumour StreamColorectal cancer
Cancer StageLocally Recurrent or Locally Advanced, Matastatic or Widespread
Anticipated Start Date2019-07-01
Anticipated End Date-

Participating Hospitals

HospitalCalvary Central Districts Hospital
Clinical Trial CoordinatorJulie Rowe
Emailjulie.rowe@calvarycare.org.au
Phone08 8239 9536
Principal InvestigatorDr Rohit Joshi
Recruitment StatusRecruiting